Company Aeolus Pharmaceuticals, Inc. OTC Bulletin Board
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Sales per Business
USD in Million | 2015 | Weight | 2016 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceutical
100.0
%
| 3 | 100.0 % | 2 | 100.0 % | -33.27% |
Sales per region
USD in Million | 2015 | Weight | 2016 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 3 | 100.0 % | 2 | 100.0 % | -33.27% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
John McManus
CEO | Chief Executive Officer | 60 | 05-05-31 |
David Cavalier
CHM | Chairman | 54 | 04-04-29 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Cavalier
CHM | Chairman | 54 | 04-04-29 |
Jeffrey Scott
BRD | Director/Board Member | 67 | 13-05-07 |
John Clerici
BRD | Director/Board Member | 54 | 13-05-07 |
Amit Kumar
BRD | Director/Board Member | 59 | 04-05-31 |
Chris Rallis
BRD | Director/Board Member | 70 | 04-05-31 |
John Farah
BRD | Director/Board Member | 72 | 05-10-20 |
Mitchell Kaye
BRD | Director/Board Member | 56 | 13-05-07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 152,085,825 | 152,085,825 ( 100.00 %) | 0 | 100.00 % |
Stock B | 0 | 4,500 | 0 | 0 |
Company contact information
Aeolus Pharmaceuticals, Inc.
26361 Crown Valley Parkway Suite 150
92691-7324, Mission Viejo
+949-481-9825
Sector
1st Jan change | Capi. | |
---|---|---|
+4.09% | 43.43B | |
+47.81% | 41.69B | |
+9.45% | 41.31B | |
-10.92% | 27.14B | |
+9.32% | 25.28B | |
-24.87% | 18.47B | |
+29.70% | 12.59B | |
+1.28% | 12.33B | |
+7.78% | 11.03B |
- Stock Market
- Equities
- AOLS Stock
- Stock
- Company Aeolus Pharmaceuticals, Inc.